NEW YORK (GenomeWeb News) – The US Department of Defense said recently that PerkinElmer Genetics has been awarded a maximum $9.7 million modification exercising the second option year of a one-year base contract with four one-year option periods for newborn screening services. "The modification is a firm-fixed-price with economic-price-adjustment, indefinite-delivery/indefinite-quantity, performance-based service contract," according to DoD. May 6, 2014 is the performance completion date. PerkinElmer did not reply to a message seeking additional information.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.